欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号MT/H/0232/001
药品名称Caspofungin Mylan Pharma 50mg powder for conentrate for solution for infusion
活性成分
    • caspofungin acetate 50.0 mg
剂型Powder for concentrate for solution for infusion/injection
上市许可持有人Mylan Pharmaceuticals Limited (NEW MAH) Damastown Industrial Park, Mulhuddart, Dublin15, Dublin, Ireland Mylan S.A.S (OLD MAH) 117 Allée des Parcs Saint-Priest 69800 France
参考成员国 - 产品名称Malta (MT)
Caspofungin Mylan50mg powder for conentrate for solution for infusion
互认成员国 - 产品名称
    • Denmark (DK)
    • Belgium (BE)
      Caspofungine Viatris
    • Norway (NO)
      Caspofungin Mylan
    • Finland (FI)
    • Slovakia (SK)
      Caspofungin Mylan 50 mg
    • Slovenia (SI)
许可日期2017/06/06
最近更新日期2023/10/06
药物ATC编码
    • J02AX04 caspofungin
申请类型
  • TypeLevel1：Known Active Substance
  • TypeLevel2：Initial Application
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase